Literature DB >> 8289338

The bovine papillomavirus type 1 (BPV1) replication protein E1 modulates transcriptional activation by interacting with BPV1 E2.

M A Le Moal1, M Yaniv, F Thierry.   

Abstract

The study of bovine papillomavirus type 1 (BPV1) DNA replication has shown that E1 and E2 are the only viral proteins required for this process. Both E1 and E2 interact with the viral origin of replication (ori). The BPV1 E2 protein is also a well-characterized transcriptional regulator. We show in this report that E1 can modulate transcription by interactions with E2. At low concentrations, E1 enhanced the E2-mediated transactivation of heterologous promoters containing the BPV1 ori by promoting cooperative binding of both E1 and E2 to the DNA. In contrast, in the presence of excess E1, transactivation by E2 is repressed. This last process, however, does not require cooperative DNA binding of the two proteins. These results imply that the balance between these two distinct types of interaction is crucial both for control of replication and for early viral transcription.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8289338      PMCID: PMC236547          DOI: 10.1128/JVI.68.2.1085-1093.1994

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Cooperative activation of transcription by bovine papillomavirus type 1 E2 can occur over a large distance.

Authors:  F Thierry; N Dostatni; F Arnos; M Yaniv
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

2.  Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells.

Authors:  E Schreiber; P Matthias; M M Müller; W Schaffner
Journal:  Nucleic Acids Res       Date:  1989-08-11       Impact factor: 16.971

3.  The bovine papillomavirus origin of replication requires a binding site for the E2 transcriptional activator.

Authors:  E Ustav; M Ustav; P Szymanski; A Stenlund
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

4.  The acidic transcriptional activation domains of VP16 and p53 bind the cellular replication protein A and stimulate in vitro BPV-1 DNA replication.

Authors:  R Li; M R Botchan
Journal:  Cell       Date:  1993-06-18       Impact factor: 41.582

5.  The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes.

Authors:  B A Bernard; C Bailly; M C Lenoir; M Darmon; F Thierry; M Yaniv
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

6.  Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters.

Authors:  H Romanczuk; F Thierry; P M Howley
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

7.  Repression of bovine papillomavirus type 1 transcription by the E1 replication protein.

Authors:  A B Sandler; S B Vande Pol; B A Spalholz
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

8.  Viral E1 and E2 proteins support replication of homologous and heterologous papillomaviral origins.

Authors:  C M Chiang; M Ustav; A Stenlund; T F Ho; T R Broker; L T Chow
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

9.  Characterization of human papillomavirus type 11 E1 and E2 proteins expressed in insect cells.

Authors:  G L Bream; C A Ohmstede; W C Phelps
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

10.  The transactivator proteins VP16 and GAL4 bind replication factor A.

Authors:  Z He; B T Brinton; J Greenblatt; J A Hassell; C J Ingles
Journal:  Cell       Date:  1993-06-18       Impact factor: 41.582

View more
  18 in total

1.  Two classes of human papillomavirus type 16 E1 mutants suggest pleiotropic conformational constraints affecting E1 multimerization, E2 interaction, and interaction with cellular proteins.

Authors:  T Yasugi; M Vidal; H Sakai; P M Howley; J D Benson
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Bovine papillomavirus type 1 E1 and simian virus 40 large T antigen share regions of sequence similarity required for multiple functions.

Authors:  K C Mansky; A Batiza; P F Lambert
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  p53 protein is a suppressor of papillomavirus DNA amplificational replication.

Authors:  D Lepik; I Ilves; A Kristjuhan; T Maimets; M Ustav
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

4.  Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis.

Authors:  C Desaintes; C Demeret; S Goyat; M Yaniv; F Thierry
Journal:  EMBO J       Date:  1997-02-03       Impact factor: 11.598

5.  Characterization of the DNA-binding domain of the bovine papillomavirus replication initiator E1.

Authors:  G Chen; A Stenlund
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

6.  Transient viral DNA replication and repression of viral transcription are supported by the C-terminal domain of the bovine papillomavirus type 1 E1 protein.

Authors:  M C Ferran; A A McBride
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

7.  The initiator protein E1 binds to the bovine papillomavirus origin of replication as a trimeric ring-like structure.

Authors:  J Sedman; A Stenlund
Journal:  EMBO J       Date:  1996-09-16       Impact factor: 11.598

8.  Amino acids critical for the functions of the bovine papillomavirus type 1 E2 transactivator.

Authors:  J L Brokaw; M Blanco; A A McBride
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

9.  The bovine papillomavirus E2 protein modulates the assembly of but is not stably maintained in a replication-competent multimeric E1-replication origin complex.

Authors:  M Lusky; J Hurwitz; Y S Seo
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

10.  Targeted mutagenesis of the human papillomavirus type 16 E2 transactivation domain reveals separable transcriptional activation and DNA replication functions.

Authors:  H Sakai; T Yasugi; J D Benson; J J Dowhanick; P M Howley
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.